Aurobindo Pharma to Produce Cabotegravir for HIV in 133 Nations

On Tuesday, Aurobindo Pharma announced that it will produce and distribute cabotegravir, a long-acting injectable HIV therapy, in 133 nations. According to a statement from the firm, the Hyderabad-based pharmaceutical company has been chosen as on

Top 10 Women Disruptors in Asia Pharmaceutical Industry

The Top 10 Women Disruptors in Asia from the Pharmaceutical Industry who are creating new pathways for innovation and impact. These inspiring leaders are from various countries throughout the continent, imparting diverse views of the future of

AstraZeneca's Baxdrostat Shows Strong BP Drop in Late-Stage Trial

AstraZeneca reported encouraging top-line results from the Phase III BaxHTN trial, demonstrating baxdrostat's statistically significant and clinically significant decrease in mean seated systolic blood pressure

Baxdrostat Phase III Trial Significantly Lowers Blood Pressure in Hypertension

Baxdrostat at two doses (2 mg and 1 mg) showed a statistically significant and clinically relevant reduction in mean sitting systolic blood pressure (SBP) at 12 weeks when compared with placebo, according to positive high-level data from the BaxHTN

WHO Endorses Gilead's Lenacapavir Shot to Boost HIV Prevention Efforts

The World Health Organization (WHO) has taken a significant step forward by endorsing Gilead's lenacapavir, an injectable drug twice-yearly, as a preventive measure to protect against HIV. The WHO confirmed this recommendation on Monday morning...

Aayush Wellness Expands Nutraceutical Range to Tap Growing Market

Aayush Wellness, a leading player in the Ayurvedic and wellness segments, has announced a strategic expansion of its nutraceutical product lines in order to bolster its presence into India's robust and emerging health and wellness sector...

Sun Pharma Introduces Alopecia Drug LEQSELVI in US Market

Sun Pharmaceutical Industries Ltd. has announced the availability of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S. to treat severe alopecia areata, a severe autoimmune disorder that unpredictably causes hair loss in adult patients.

Sun Pharma to Invest Rs 3,800 Cr in MP, Boosting Jobs and Growth

In a substantial move for India's pharmaceutical manufacturing sector, Sun Pharmaceutical Industries has committed to an investment of Rs 3,800 crore in Madhya Pradesh, creating an estimated 2,000 new jobs...

Rajasthan Expands Nationwide AI-Based Diabetic Eye Screening

In a significant advancement for artificial intelligence technology's application to public health, Rajasthan's MadhuNetr DR-AI programme, which uses AI to assist screening for diabetic retinopathy, has received approval by the government for...

AFMS Plans Drone Deliveries of Blood and Medicines to Remote Areas

In a significant move towards the evolution of military healthcare logistics, the Armed Forces Medical Services (AFMS) is investigating the feasibility of using drones for transportation of blood bags, medicines and emergency supplies, to remote...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.